Have First Line Practice Patterns in the Treatment of Follicular Lymphoma Changed with the Adoption of Maintenance Rituximab?

Examine the first line (1L) practice patterns, including adoption of maintenance rituximab (MR), in follicular lymphoma (FL) patients in the Veterans Health Administration (VHA) from 2006-2015.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research
More News: Leukemia | Lymphoma | Myeloma | Rituxan